The Enterprise Value as of December 2025 (TTM) for OSE Immunotherapeutics S.A. (OSE.PA) is 125.94M

According to OSE Immunotherapeutics S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 125.94M. This represents a change of -4.66% compared to the average of 132.09M of the last 4 quarters.

OSE Immunotherapeutics S.A. (OSE.PA) Historical Enterprise Value (quarterly & annually)

How has OSE.PA Enterprise Value performed in the past?

The mean historical Enterprise Value of OSE Immunotherapeutics S.A. over the last ten years is 102.44M. The current 125.94M Enterprise Value has changed 12.19% with respect to the historical average. Over the past ten years (40 quarters), OSE.PA's Enterprise Value was at its highest in in the June 2021 quarter at 206.62M. The Enterprise Value was at its lowest in in the June 2012 quarter at 0.

OSE Immunotherapeutics S.A. (OSE.PA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of OSE Immunotherapeutics S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

OSE Immunotherapeutics S.A. (OSE.PA) Average Enterprise Value

How has OSE.PA Enterprise Value performed in the past?

The current Enterprise Value of OSE Immunotherapeutics S.A. (OSE.PA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

OSE Immunotherapeutics S.A. (OSE.PA) Enterprise Value vs. Peers

How is OSE.PA’s Enterprise Value compared to its peers?

OSE Immunotherapeutics S.A.’s Enterprise Value is greater than ABIONYX Pharma S.A. (122.42M), greater than Innate Pharma S.A. (124.13M), greater than Sensorion S.A. (57.66M), less than Adocia S.A. (133.26M), greater than Crossject S.A. (119.64M), less than Transgene S.A. (139.51M), less than Genfit S.A. (285.61M), greater than MaaT Pharma S.A. (63.60M), less than Median Technologies S.A. (151.25M), less than Cellectis S.A. (388.29M),

Build a custom stock screener for OSE Immunotherapeutics S.A. (OSE.PA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OSE Immunotherapeutics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OSE Immunotherapeutics S.A. (OSE.PA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OSE Immunotherapeutics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.